CVS Health

CVS Health Stock on December 2, 2025: Insulin Settlement, Analyst Targets and What’s Next for NYSE: CVS

As of December 2, 2025, CVS Health Corporation (NYSE: CVS) finds itself in a classic “good news, bad headlines” moment: the stock has pulled back after a strong 2025 rally, the company agreed to a federal settlement over insulin-pen billing,

3 December 2025

CVS Health Stock in December 2025: Price, Forecast, Dividend and Whether the Rally Still Has Room to Run

Data and news current as of December 1, 2025. This article is for informational purposes only and is not financial advice. CVS Health Stock Today: A Big 2025 Comeback, Slightly Off the Highs CVS Health Corporation (NYSE: CVS) has staged

2 December 2025

Dividend Stocks · Financial Forecasts · Healthcare Industry · Investing · NYSE:CVS · Stock Market

CVS Health Stock Today (NYSE: CVS): Institutional Buying, New Board Chair and Q3 Shock Shape Outlook – November 23, 2025

CVS Health stock is heading into the new week near the top of its 2025 trading range after a year of sharp gains, a headline‑grabbing goodwill write‑down, and a wave of fresh institutional ownership filings released today, November 23, 2025.

23 November 2025

Company News · Financial Reports · Healthcare Industry · Investment Analysis · Stock Market

CVS Health Stock Rockets After Blockbuster Q3 Results, Raises Profit Outlook

In Wednesday’s earnings announcement, CVS Health (NYSE: CVS) beat expectations across the board. The pharmacy-and-insurance giant reported Q3 total sales of $102.9 billion and adjusted profit of $1.60 per share cvshealth.com gurufocus.com, handily exceeding consensus. Revenue was about $7.5 billion higher than

29 October 2025

Earnings Reports · Financial News · Health Care · Investment · NYSE:CVS · Stock Market